Philip P. Mortimer

6.4k total citations · 1 hit paper
111 papers, 4.5k citations indexed

About

Philip P. Mortimer is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Philip P. Mortimer has authored 111 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 30 papers in Epidemiology and 25 papers in Virology. Recurrent topics in Philip P. Mortimer's work include Parvovirus B19 Infection Studies (24 papers), HIV Research and Treatment (20 papers) and Blood groups and transfusion (14 papers). Philip P. Mortimer is often cited by papers focused on Parvovirus B19 Infection Studies (24 papers), HIV Research and Treatment (20 papers) and Blood groups and transfusion (14 papers). Philip P. Mortimer collaborates with scholars based in United Kingdom, Nepal and United States. Philip P. Mortimer's co-authors include B J Cohen, Neal S. Young, John Parry, Marcelo de Souza Fernandes Pereira, R. Keith Humphries, John F. Kelleher, Naomi L.C. Luban, JG Moore, D R Blake and Anthony D. Woolf and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Philip P. Mortimer

103 papers receiving 4.1k citations

Hit Papers

HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFT... 1983 2026 1997 2011 1983 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip P. Mortimer United Kingdom 36 3.3k 1.7k 1.0k 825 605 111 4.5k
B J Cohen United Kingdom 39 3.7k 1.1× 2.4k 1.4× 1.3k 1.3× 1.2k 1.4× 667 1.1× 102 5.1k
Michael Kidd United Kingdom 32 1.9k 0.6× 668 0.4× 1.5k 1.5× 359 0.4× 147 0.2× 65 3.7k
Kristina Broliden Sweden 37 1.9k 0.6× 675 0.4× 1.3k 1.3× 435 0.5× 194 0.3× 157 4.7k
Yvonne E. Cossart Australia 30 1.3k 0.4× 570 0.3× 1.7k 1.6× 263 0.3× 142 0.2× 126 4.1k
Bernard Cohen United Kingdom 23 1.7k 0.5× 1.1k 0.6× 575 0.6× 611 0.7× 215 0.4× 44 2.3k
Anna Maria Eis‐Hübinger Germany 35 1.6k 0.5× 490 0.3× 1.4k 1.4× 238 0.3× 102 0.2× 102 3.5k
Richard L. Hodinka United States 36 1.5k 0.5× 188 0.1× 1.8k 1.8× 175 0.2× 113 0.2× 108 3.7k
Adriana Weinberg United States 45 1.2k 0.4× 357 0.2× 4.3k 4.2× 146 0.2× 184 0.3× 234 6.3k
Rafael Harpaz United States 40 1.3k 0.4× 972 0.6× 5.1k 5.1× 86 0.1× 130 0.2× 95 6.9k
Yvonne J. Bryson United States 41 2.8k 0.8× 166 0.1× 2.8k 2.8× 246 0.3× 164 0.3× 143 6.3k

Countries citing papers authored by Philip P. Mortimer

Since Specialization
Citations

This map shows the geographic impact of Philip P. Mortimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip P. Mortimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip P. Mortimer more than expected).

Fields of papers citing papers by Philip P. Mortimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip P. Mortimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip P. Mortimer. The network helps show where Philip P. Mortimer may publish in the future.

Co-authorship network of co-authors of Philip P. Mortimer

This figure shows the co-authorship network connecting the top 25 collaborators of Philip P. Mortimer. A scholar is included among the top collaborators of Philip P. Mortimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip P. Mortimer. Philip P. Mortimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mortimer, Philip P.. (2009). Alexander Fleming, citrated blood and penicillin: paths not pursued and applications delayed. Transfusion Medicine. 19(6). 304–308. 2 indexed citations
2.
Rogstad, K E, Adrian Palfreeman, G Rooney, et al.. (2006). UK National Guidelines on HIV Testing 2006. International Journal of STD & AIDS. 17(10). 668–676. 96 indexed citations
3.
Mortimer, Philip P.. (2006). Robert Cory and the vaccine syphilis controversy: a forgotten hero?. The Lancet. 367(9516). 1112–1115. 1 indexed citations
4.
Parry, John V., Philip P. Mortimer, Keith R. Perry, Deenan Pillay, & Mark Zuckerman. (2003). Towards error-free HIV diagnosis: guidelines on laboratory practice.. PubMed. 6(4). 334–50. 19 indexed citations
5.
Parry, Jane, Gary Murphy, K. L. Barlow, et al.. (2001). National Surveillance of HIV-1 Subtypes for England and Wales. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(4). 381–388. 42 indexed citations
6.
Theiler, Max, H. Smith, & Philip P. Mortimer. (2000). The use of yellow fever virus modified byin vitro cultivation for human immunization. Reviews in Medical Virology. 10(1). 3–16. 19 indexed citations
7.
Ponzetto, Antonio, Rinaldo Pellicano, Nicola Leone, et al.. (2000). Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?. Medical Hypotheses. 54(2). 275–277. 70 indexed citations
8.
Evans, B G, Jane Parry, & Philip P. Mortimer. (1997). HIV antibody assay that gave false negative results: multicentre collaborative study. BMJ. 315(7111). 772–774. 3 indexed citations
9.
Parry, John, et al.. (1995). GACPAT HIV 1+2: A simple, inexpensive assay to screen for, and discriminate between, anti‐HIV 1 and anti‐HIV 2. Journal of Medical Virology. 45(1). 10–16. 19 indexed citations
10.
Hawkes, Sarah, Graham Hart, Margaret Johnson, et al.. (1994). Risk behaviour and HIV prevalence in international travellers. AIDS. 8(2). 247–252. 75 indexed citations
11.
Mortimer, Philip P. & John Parry. (1994). Detection of antibody to HIV in saliva: a brief review. Clinical and Diagnostic Virology. 2(4-5). 231–243. 52 indexed citations
12.
Brennan, Matt, J. A. J. Barbara, M. Contreras, et al.. (1993). Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.. BMJ. 307(6914). 1235–1239. 45 indexed citations
13.
Lillo, Flavia, Oliviero E. Varnier, A Terragna, et al.. (1992). Detection of HIV-1 antibodies in blood specimens spotted on filter-paper.. Europe PMC (PubMed Central). 70(3). 323–6. 11 indexed citations
14.
Wyld, P.J., Jennifer Tosswill, Philip P. Mortimer, & Jonathan Weber. (1990). SPORADIC HTLV‐I ASSOCIATED ADULT T‐CELL LEUKAEMIA (ATL) IN THE U.K.. British Journal of Haematology. 76(1). 149–150. 6 indexed citations
15.
Johnson, Margaret, et al.. (1988). HIV surveillance by testing saliva. AIDS. 2(5). 369–372. 82 indexed citations
16.
Mortimer, Philip P., et al.. (1985). Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84.. BMJ. 290(6476). 1176–1178. 33 indexed citations
17.
Okochi, K., et al.. (1985). Human parvovirus (B19) and erythema infectiosum. The Journal of Pediatrics. 107(1). 38–40. 74 indexed citations
18.
Marsh, Grenville, et al.. (1984). Human parvovirus aplasia: case due to cross infection in a ward.. BMJ. 288(6418). 681.1–681. 48 indexed citations
19.
Kelleher, John F., Naomi L.C. Luban, Philip P. Mortimer, & Tomoteru Kamimura. (1983). Human serum “parvovirus”: A specific cause of aplastic crisis in children with hereditary spherocytosis. The Journal of Pediatrics. 102(5). 720–722. 103 indexed citations
20.
Shneerson, John M., Philip P. Mortimer, & E M Vandervelde. (1980). Febrile illness due to a parvovirus.. BMJ. 280(6231). 1580.1–1580. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026